Sattler M, Liang H, Nettesheim D, Meadows R P, Harlan J E, Eberstadt M, Yoon H S, Shuker S B, Chang B S, Minn A J, Thompson C B, Fesik S W
Pharmaceutical Discovery Division, Abbott Laboratories, Abbott Park, IL 60064, USA.
Science. 1997 Feb 14;275(5302):983-6. doi: 10.1126/science.275.5302.983.
Heterodimerization between members of the Bcl-2 family of proteins is a key event in the regulation of programmed cell death. The molecular basis for heterodimer formation was investigated by determination of the solution structure of a complex between the survival protein Bcl-xL and the death-promoting region of the Bcl-2-related protein Bak. The structure and binding affinities of mutant Bak peptides indicate that the Bak peptide adopts an amphipathic alpha helix that interacts with Bcl-xL through hydrophobic and electrostatic interactions. Mutations in full-length Bak that disrupt either type of interaction inhibit the ability of Bak to heterodimerize with Bcl-xL.
Bcl-2蛋白家族成员之间的异源二聚化是程序性细胞死亡调控中的关键事件。通过测定存活蛋白Bcl-xL与Bcl-2相关蛋白Bak的促死亡区域之间复合物的溶液结构,研究了异源二聚体形成的分子基础。突变型Bak肽的结构和结合亲和力表明,Bak肽形成一种两亲性α螺旋,通过疏水和静电相互作用与Bcl-xL相互作用。全长Bak中破坏任何一种相互作用类型的突变都会抑制Bak与Bcl-xL异源二聚化的能力。